These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26280203)

  • 1. SAFETY AND EFFICACY OF A PERI-OPERATIVE PROTOCOL FOR PATIENTS WITH DIABETES TREATED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION WHO ARE ADMITTED FOR SAME-DAY SURGERY.
    Sobel SI; Augustine M; Donihi AC; Reider J; Forte P; Korytkowski M
    Endocr Pract; 2015 Nov; 21(11):1269-76. PubMed ID: 26280203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of insulin pump therapy (continuous subcutaneous insulin infusion) to alternative methods for perioperative glycemic management in patients with planned postoperative admissions.
    Corney SM; Dukatz T; Rosenblatt S; Harrison B; Murray R; Sakharova A; Balasubramaniam M
    J Diabetes Sci Technol; 2012 Sep; 6(5):1003-15. PubMed ID: 23063025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized glycemic management and perioperative glycemic outcomes in patients with diabetes mellitus who undergo same-day surgery.
    DiNardo M; Donihi AC; Forte P; Gieraltowski L; Korytkowski M
    Endocr Pract; 2011; 17(3):404-11. PubMed ID: 21247843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient outcomes after implementation of a protocol for inpatient insulin pump therapy.
    Noschese ML; DiNardo MM; Donihi AC; Gibson JM; Koerbel GL; Saul M; Stefanovic-Racic M; Korytkowski MT
    Endocr Pract; 2009; 15(5):415-24. PubMed ID: 19491071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative glycemic management in insulin pump patients undergoing noncardiac surgery.
    Abdelmalak B; Ibrahim M; Yared JP; Modic MB; Nasr C
    Curr Pharm Des; 2012; 18(38):6204-14. PubMed ID: 22762462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion reduces the risk of postoperative infection.
    Mou Y; Ma D; Zhang J; Tao J; He W; Li W; Mu Y; Yu X
    J Diabetes; 2020 May; 12(5):396-405. PubMed ID: 31697444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on a Quality Initiative to Standardize Perioperative Care for Continuous Subcutaneous Insulin Infusion Therapy.
    Mackey PA; Thompson BM; Boyle ME; Apsey HA; Seifert KM; Schlinkert RT; Stearns JD; Cook CB
    J Diabetes Sci Technol; 2015 Jun; 9(6):1299-306. PubMed ID: 26092687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anesthesiological perspectives on perioperative management in continuous subcutaneous insulin infusion (CSII): stop or continue?].
    Kietaibl AT; Kietaibl S
    Wien Med Wochenschr; 2020 May; 170(7-8):155-167. PubMed ID: 31654155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLYCEMIC OUTCOMES 3 YEARS AFTER IMPLEMENTATION OF A PERI-OPERATIVE GLYCEMIC CONTROL ALGORITHM IN AN ACADEMIC INSTITUTION.
    Arnold LM; Mahesri M; McDonnell ME; Alexanian SM
    Endocr Pract; 2017 Feb; 23(2):123-131. PubMed ID: 27819771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital.
    Thompson B; Korytkowski M; Klonoff DC; Cook CB
    J Diabetes Sci Technol; 2018 Jul; 12(4):880-889. PubMed ID: 29681173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
    Raskin P; Bode BW; Marks JB; Hirsch IB; Weinstein RL; McGill JB; Peterson GE; Mudaliar SR; Reinhardt RR
    Diabetes Care; 2003 Sep; 26(9):2598-603. PubMed ID: 12941725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
    Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
    Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of continuous subcutaneous insulin infusion (CSII) therapy in pediatric diabetes patients in the perioperative period.
    Vanderhoek SM; Wolf RM
    Paediatr Anaesth; 2019 Sep; 29(9):901-906. PubMed ID: 31325198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of sitagliptin in combination with transient continuous subcutaneous insulin infusion (CSII) therapy in patients with newly diagnosed type 2 diabetes.
    Yuan G; Jia J; Zhang C; Yu S; Dong S; Ye J; Zhu T; Tang B; Qian W; Wang D; Yang L; Zhou L; Mao C
    Endocr J; 2014; 61(5):513-21. PubMed ID: 24621778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.